Intesa invests 360 million euros for full control of health insurance business
Reuters
Published Mar 02, 2023 10:57
Updated Mar 02, 2023 11:27
MILAN (Reuters) - Italy's biggest bank Intesa Sanpaolo (BIT:ISP) on Thursday said it would spend 360 million euros ($382 million) in cash to buy the 26.2% of healthcare insurer Intesa (LON:0HBC) Sanpaolo RBM Salute it did does not own.
Intesa Sanpaolo Vita, the group's insurance arm, bought 50% plus one share of RBM from its owners, the Favaretto family's holding company, for 325 million euros back in 2020.
It injected more capital into the business at the end of 2021 via a new share issue in which the Favaretto family did not take part, seeing their stake reduced to 26.2%.
Intesa has moved to take full control of RBM ahead of two call options set in 2026 and 2029.
KPMG Corporate Finance and Pedersoli acted as financial and legal advisers, respectively.
The deal aims to develop Intesa Sanpaolo RBM Salute's business through growing synergies with the rest of the group, the bank said in a note.
($1 = 0.9413 euros)
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.